BIVI

BIOVIE INC.

Healthcare Pharmaceutical Preparations Market cap: $10.3M All insider activity → Quote and statistics → Sign in to watch BIVI Sign in to set a price alert

AI summary Insiders buy open-market shares following positive Phase 2 clinical trial results.

Insider Score Band below 60

Research score: 44
AI adjustment: +9

Research score, not a recommendation.

Total bought$49.1K4 Form 4 purchases

Distinct insiders4open-market buyers

Lead insiderDO CUONG VCEO

Cluster window2026-08-27 → 2026-08-28active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders

63%

Seniority executive rank of buyers (CEO/CFO/Director)

97%

Commitment purchase size relative to company & holdings

89%

Context buying into stock weakness signals conviction

Timing coordinated purchases within a tight window

100%

Routine-purchase discount × 1.00

Company-type / offering discount × 1.00

Net insider selling penalty − 0

Why are they buying?

AI · discretionary · catalyst credible · documented

Insiders made discretionary open-market purchases shortly after the company announced successful topline results from its Phase 2 SUNRISE-PD trial evaluating bezisterim in early-stage Parkinson's disease.

The Phase 2 trial successfully met prespecified endpoints, showing statistically significant improvements in both motor and non-motor symptoms compared to placebo.

Filing references and sources

BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease Patients (opens in a new tab)

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

4 Form 4 trades · 4 insiders Sign in to download CSV

Purchases in this cluster, grouped by insider, largest first
Date	Insider	Role	Shares	Price	Value	Filing
2026-08-27	DO CUONG V history of DO CUONG V's purchases	CEO	15,210	$2.08	$31.6K	SEC filing for DO CUONG V (opens in a new tab)
2026-08-28	Palumbo Joseph M history of Palumbo Joseph M's purchases	Other C-suite	4,843	$2.16	$10.5K	SEC filing for Palumbo Joseph M (opens in a new tab)
2026-08-28	KIM JOANNE WENDY history of KIM JOANNE WENDY's purchases	CFO	2,500	$2.18	$5.5K	SEC filing for KIM JOANNE WENDY (opens in a new tab)
2026-08-28	Chappell Amy Suzon history of Chappell Amy Suzon's purchases	Director	727	$2.16	$1.6K	SEC filing for Chappell Amy Suzon (opens in a new tab)
Total					$49.1K

What happened next

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days -30.4%63 days –126 days –